Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Sep 21, 2023

BUY
$43.66 - $61.0 $873,199 - $1.22 Million
20,000 Added 139.86%
34,300 $1.85 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $873,199 - $1.22 Million
20,000 Added 139.86%
34,300 $1.85 Million
Q2 2022

Sep 21, 2023

SELL
$28.82 - $77.35 $1.37 Million - $3.67 Million
-47,400 Reduced 76.82%
14,300 $576,000
Q2 2022

Aug 15, 2022

SELL
$28.82 - $77.35 $1.37 Million - $3.67 Million
-47,400 Reduced 76.82%
14,300 $577,000
Q4 2021

Sep 21, 2023

BUY
$88.71 - $120.43 $5.34 Million - $7.25 Million
60,200 Added 4013.33%
61,700 $6.17 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $5.34 Million - $7.25 Million
60,200 Added 4013.33%
61,700 $6.17 Million
Q3 2021

Sep 21, 2023

SELL
$98.77 - $132.17 $493,850 - $660,849
-5,000 Reduced 76.92%
1,500 $187,000
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $493,850 - $660,849
-5,000 Reduced 76.92%
1,500 $188,000
Q2 2021

Sep 21, 2023

BUY
$109.77 - $165.68 $164,655 - $248,520
1,500 Added 30.0%
6,500 $807,000
Q2 2021

Aug 20, 2021

SELL
$109.77 - $165.68 $70.6 Million - $107 Million
-643,500 Reduced 99.0%
6,500 $807,000
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $70.8 Million - $107 Million
645,000 Added 12900.0%
650,000 $807,000
Q1 2021

Sep 21, 2023

SELL
$127.04 - $179.1 $3.72 Million - $5.25 Million
-29,300 Reduced 85.42%
5,000 $763,000
Q1 2021

May 14, 2021

BUY
$127.04 - $179.1 $635,200 - $895,500
5,000 New
5,000 $763,000
Q4 2019

Feb 13, 2020

SELL
$59.49 - $82.78 $565,155 - $786,410
-9,500 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$62.59 - $110.3 $206,547 - $363,990
3,300 Added 53.23%
9,500 $606,000
Q2 2019

Aug 14, 2019

SELL
$63.94 - $91.11 $466,762 - $665,103
-7,300 Reduced 54.07%
6,200 $535,000
Q1 2019

May 15, 2019

BUY
$34.3 - $97.98 $463,049 - $1.32 Million
13,500 New
13,500 $1.04 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.